OBJECTIVE: To evaluate Vgamma2Vdelta2 T cells in a group of HIV-infected patients who suppress HIV replication without antiretroviral therapy (natural viral suppressors, NVSs). DESIGN: : It is a cross-sectional study. METHODS: We compared Vgamma2Vdelta2 T-cell frequency, T-cell repertoire, and responses to isopentenyl pyrophosphate stimulation between NVSs (n = 21) and HIV-uninfected controls (n = 27) and between NVSs and HIV-infected patients taking HAART with suppressed viral replication (HIV-P; n = 25). RESULTS: NVSs had a mean frequency of 1.06 +/- 0.82% CD3Vdelta2+ cells among total lymphocytes, which was significantly higher than both control groups (HIV-negative: 0.50 +/- 0.53%, P = 0.042; HIV-P: 0.34 +/- 0.37%, P = 0.002). The proportion of Vgamma2 chains correlating with the Vgamma2-Jgamma1.2 rearrangement was reduced among NVSs compared with HIV-negative controls (0.57 +/- 0.06 vs. 0.32 +/- 0.04; P = 0.016) but was increased compared with HIV-P patients (0.32 +/- 0.04 vs. 0.22 +/- 0.03; P = 0.03). NVSs had a similar baseline frequency of CD27/CD45RA effector cells (19.6 +/- 4.2%) compared with HIV-negative controls (20.8 +/- 12.9%; P = 0.35). CONCLUSION: The altered gammadelta T-cell receptor repertoire among NVS was consistent with the known effect of HIV-1 on these cells. Uniquely among all HIV-infected groups, NVS reconstituted the gammadelta T-cell population, eventually reaching levels significantly above controls. This capacity to recover gammadelta T-cell numbers and function distinguishes individuals who control HIV-1 with and without HAART.
OBJECTIVE: To evaluate Vgamma2Vdelta2 T cells in a group of HIV-infectedpatients who suppress HIV replication without antiretroviral therapy (natural viral suppressors, NVSs). DESIGN: : It is a cross-sectional study. METHODS: We compared Vgamma2Vdelta2 T-cell frequency, T-cell repertoire, and responses to isopentenyl pyrophosphate stimulation between NVSs (n = 21) and HIV-uninfected controls (n = 27) and between NVSs and HIV-infectedpatients taking HAART with suppressed viral replication (HIV-P; n = 25). RESULTS: NVSs had a mean frequency of 1.06 +/- 0.82% CD3Vdelta2+ cells among total lymphocytes, which was significantly higher than both control groups (HIV-negative: 0.50 +/- 0.53%, P = 0.042; HIV-P: 0.34 +/- 0.37%, P = 0.002). The proportion of Vgamma2 chains correlating with the Vgamma2-Jgamma1.2 rearrangement was reduced among NVSs compared with HIV-negative controls (0.57 +/- 0.06 vs. 0.32 +/- 0.04; P = 0.016) but was increased compared with HIV-Ppatients (0.32 +/- 0.04 vs. 0.22 +/- 0.03; P = 0.03). NVSs had a similar baseline frequency of CD27/CD45RA effector cells (19.6 +/- 4.2%) compared with HIV-negative controls (20.8 +/- 12.9%; P = 0.35). CONCLUSION: The altered gammadelta T-cell receptor repertoire among NVS was consistent with the known effect of HIV-1 on these cells. Uniquely among all HIV-infected groups, NVS reconstituted the gammadelta T-cell population, eventually reaching levels significantly above controls. This capacity to recover gammadelta T-cell numbers and function distinguishes individuals who control HIV-1 with and without HAART.
Authors: Patrick J Enders; Cheng Yin; Federico Martini; Peter S Evans; Nadia Propp; Fabrizio Poccia; C David Pauza Journal: AIDS Res Hum Retroviruses Date: 2003-01-01 Impact factor: 2.205
Authors: S A Migueles; M S Sabbaghian; W L Shupert; M P Bettinotti; F M Marincola; L Martino; C W Hallahan; S M Selig; D Schwartz; J Sullivan; M Connors Journal: Proc Natl Acad Sci U S A Date: 2000-03-14 Impact factor: 11.205
Authors: Jose Bordon; Peter S Evans; Nadia Propp; Charles E Davis; Robert R Redfield; C David Pauza Journal: J Infect Dis Date: 2004-03-30 Impact factor: 5.226
Authors: C M Parker; V Groh; H Band; S A Porcelli; C Morita; M Fabbi; D Glass; J L Strominger; M B Brenner Journal: J Exp Med Date: 1990-05-01 Impact factor: 14.307
Authors: Cristiana Cairo; Nyaradzo Longinaker; Giulia Cappelli; Rose G F Leke; Manuel Mve Ondo; Rosine Djokam; Josephine Fogako; Robert J Leke; Bertrand Sagnia; Samuel Sosso; Vittorio Colizzi; C David Pauza Journal: J Infect Dis Date: 2013-12-10 Impact factor: 5.226
Authors: Anna M Sherwood; Cindy Desmarais; Robert J Livingston; Jessica Andriesen; Maximilian Haussler; Christopher S Carlson; Harlan Robins Journal: Sci Transl Med Date: 2011-07-06 Impact factor: 17.956
Authors: Sarah Boudova; Haishan Li; Mohammad M Sajadi; Robert R Redfield; Cristiana Cairo; C David Pauza Journal: J Infect Dis Date: 2013-04-01 Impact factor: 5.226
Authors: Wendy E Walker; Sebastian Kurscheid; Samit Joshi; Charlie A Lopez; Gerald Goh; Murim Choi; Lydia Barakat; John Francis; Ann Fisher; Michael Kozal; Heidi Zapata; Albert Shaw; Richard Lifton; Richard E Sutton; Erol Fikrig Journal: J Virol Date: 2015-03-04 Impact factor: 5.103